Novel squalene-hopene cyclase inhibitors derived from hydroxycoumarins and hydroxyacetophenones.
Giancarlo Cravotto, Gianni Balliano, Silvia Tagliapietra, Simonetta Oliaro-Bosso, Gian Mario Nano
Index: Chem. Pharm. Bull. 52(10) , 1171-4, (2004)
Full Text: HTML
Abstract
Squalene-hopene cyclase (SHC) is a useful model enzyme for predicting molecular interactions with oxidosqualene cyclase (OSC). Structure--activity relationships were investigated for numerous coumarin-derived inhibitors of SHC, and structural simplifications are suggested. Both umbelliferone and 2,4-dihydroxyacetophenone provide convenient starting nuclei for the design of SHC inhibitors. Derivatives bearing an omega-epoxyfarnesyl moiety or just a plain alkyl chain showed an inhibitory effect on a recombinant SHC from Alicyclobacillus acidocaldarius expressed in Escherichia coli.
Related Compounds
Related Articles:
Molecular modeling and inhibition of phospholipase A2by polyhydroxy phenolic compounds
2009-01-01
[Eur. J. Med. Chem. 44 , 312-21, (2009)]
MALDI mass spectrometry in the solution of some forensic problems.
2004-12-02
[Forensic Sci. Int. 146 Suppl , S83-5, (2004)]
Study of the acute human health effects of intermediates in the synthesis of sodium cromoglycate.
1995-04-01
[Ann. Occup. Hyg. 39(2) , 235-40, (1995)]
Enhanced MALDI-TOF MS analysis of phosphopeptides using an optimized DHAP/DAHC matrix.
2010-01-01
[J. Biomed. Biotechnol. 2010 , 759690, (2010)]
Inhibitory effects of choleretic hydroxyacetophenones on ileal bile acid transport in rats.
2006-02-28
[Life Sci. 78(14) , 1630-6, (2006)]